**Question:** The immunosuppressant action of cyclosporin appears to be due to

A. Calcineurin inhibition
B. Calmodulin inhibition
C. Inhibition of lymphocyte proliferation
D. Interleukin-2 production

**Correct Answer:** A. Calcineurin inhibition

**Core Concept:**
Cyclosporin is a immunosuppressive drug used in organ transplantation to prevent rejection and in autoimmune diseases. Its primary mechanism of action involves the inhibition of calcineurin, which is a calcium-dependent serine/threonine protein phosphatase. Calcineurin plays a crucial role in the activation of transcription factors, such as nuclear factor of activated T cells (NF-AT), which are essential for T cell activation and proliferation.

**Why the Correct Answer is Right:**
Cyclosporin inhibits calcineurin by binding to cyclophilin, forming a complex that sequesters calcineurin in the cytoplasm, preventing it from entering the nucleus and dephosphorylating NF-AT. This inhibition of calcineurin results in the suppression of T cell activation and proliferation, ultimately leading to immunosuppression.

**Why Each Wrong Option is Incorrect:**

A. Calmodulin inhibition: Cyclosporin primarily targets calcineurin, not calmodulin. Calmodulin inhibition is not the primary mechanism of action for cyclosporin-induced immunosuppression.

B. Calmodulin is a calcium-dependent protein that binds to and regulates various enzymes, including myosin light chain kinase and calpain, but it is not the primary target of cyclosporin's immunosuppressive effects.

C. While cyclosporin does inhibit lymphocyte proliferation, this option is not specific to the primary mechanism of action involving calcineurin inhibition.

D. Interleukin-2 production: Although interleukin-2 is a cytokine involved in T cell activation, the primary mechanism of action of cyclosporin lies in the inhibition of calcineurin, not interleukin-2 production.

**Clinical Pearl:**
Understanding the primary mechanism of action of cyclosporin is crucial for its proper use in immunosuppressive therapy. The immunosuppressive effects of cyclosporin are mainly mediated by its inhibition of calcineurin, which in turn suppresses T cell activation and proliferation. By preventing the production of cytokines, such as interleukin-2, cyclosporin helps to reduce the risk of organ transplant rejection and is beneficial in conditions like rheumatoid arthritis, psoriasis, and inflammatory bowel disease by suppressing the immune response.